Literature DB >> 8648831

Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1.

J A Brown1, S Takahashi, A Alcaraz, T J Borell, K L Anderl, J Qian, D L Persons, D G Bostwick, M M Lieber, R B Jenkins.   

Abstract

PURPOSE: Cytogenetic studies of a small number of renal oncocytomas have indicated that loss of chromosomes 1 and Y may be involved in the pathogenesis of this tumor. To evaluate these observations further we selected paraffin embedded renal oncocytoma specimens from 20 male and 10 female patients for fluorescence in situ hybridization analysis.
MATERIALS AND METHODS: Isolated nuclei were prepared from paraffin embedded specimens, and fluorescence in situ hybridization was performed with enumeration probes for chromosomes 1, 12, X and Y.
RESULTS: Tumors from 10 male (50%) and 4 female (40%) patients demonstrated chromosomal alterations. Loss of chromosome Y was observed in specimens from all 10 male patients, and loss of chromosome 1 or gain of chromosome 12 was noted in 5 and 2 of these specimens, respectively. Of the 4 female patients with chromosomal abnormalities 2 had loss of chromosome 1, 1 had gain of chromosome 1 and 1 had gain of chromosome 12.
CONCLUSIONS: Our results confirm that loss of chromosomes Y and 1 is common in renal oncocytoma, and that the alterations are probably involved in the pathogenesis of this tumor.

Entities:  

Mesh:

Year:  1996        PMID: 8648831

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  Renal oncocytoma with a novel chromosomal rearrangement, der(13)t(13;16)(p11;p11), associated with a renal cell carcinoma.

Authors:  X Leroy; E Leteurtre; P H Mahe; B Gosselin; B Delobel; M F Croquette
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

Review 2.  Renal cell carcinoma deep sequencing: recent developments.

Authors:  Leslie J Farber; Kyle Furge; Bin Tean Teh
Journal:  Curr Oncol Rep       Date:  2012-06       Impact factor: 5.075

3.  Molecular classification of renal tumors by gene expression profiling.

Authors:  Audrey N Schuetz; Qiqin Yin-Goen; Mahul B Amin; Carlos S Moreno; Cynthia Cohen; Christopher D Hornsby; Wen Li Yang; John A Petros; Muta M Issa; John G Pattaras; Kenneth Ogan; Fray F Marshall; Andrew N Young
Journal:  J Mol Diagn       Date:  2005-05       Impact factor: 5.568

4.  Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers.

Authors:  A N Young; M B Amin; C S Moreno; S D Lim; C Cohen; J A Petros; F F Marshall; A S Neish
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

Review 5.  Oncocytic mania: a review of oncocytic lesions throughout the body.

Authors:  F Guaraldi; G Zang; A P Dackiw; P Caturegli
Journal:  J Endocrinol Invest       Date:  2011-02-07       Impact factor: 4.256

Review 6.  Molecular differential diagnosis of renal carcinoma: from microscopes to microsatellites.

Authors:  G Steiner; D Sidransky
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

Review 7.  Update on oncocytoma.

Authors:  Stephen M Schatz; Michael M Lieber
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 3.092

8.  Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up.

Authors:  Marie Dvorakova; Rajiv Dhir; Sheldon I Bastacky; Kathleen M Cieply; Marie B Acquafondata; Carol R Sherer; Tracy L Mercuri; Anil V Parwani
Journal:  Diagn Pathol       Date:  2010-05-24       Impact factor: 2.644

Review 9.  Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms.

Authors:  Ning Yi Yap; Retnagowri Rajandram; Keng Lim Ng; Jayalakshmi Pailoor; Ahmad Fadzli; Glenda Carolyn Gobe
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.